Serotonergic agonists and antagonists affect endurance performance in the rat

Int J Sports Med. 1993 Aug;14(6):330-3. doi: 10.1055/s-2007-1021187.

Abstract

The purpose of this experiment was to examine the effects of administration of serotonergic (5-HT) agonist and antagonist drugs on run-time to exhaustion (RUN-EXH) in male and female rats. RUN-EXH was reduced (p < 0.05) in a dose related manner by increasing dosages of quipazine dimaleate (QD: general 5-HT agonist) (0-5 mg.kg-1 i.p.) administered immediately prior to exercise (treadmill running at 20 m.min-1 and 5% grade). Conversely, RUN-EXH was increased (p < 0.05) by the greatest dosage of LY 53,857 (LY: 5-HT1C and 5-HT2 antagonist) (1.5 mg.kg-1 i.p.). Drug effects were similar in male and female rats. The negative effects of QD administration on RUN-EXH were not attenuated by administration of the peripherally restricted antagonist, xylamidine tosylate (up to 200 ug.kg-1 i.p.). The results of this investigation indicated that fatigue during prolonged exercise can be influenced by direct pharmacological administration of a serotonergic agonist and antagonist and that the mechanisms underlying these effects are likely to be central (brain) in nature.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amidines / administration & dosage
  • Amidines / pharmacology*
  • Animals
  • Dose-Response Relationship, Drug
  • Ergolines / administration & dosage
  • Ergolines / pharmacology*
  • Female
  • Injections, Intraperitoneal
  • Male
  • Physical Endurance / drug effects*
  • Placebos
  • Quipazine / administration & dosage
  • Quipazine / pharmacology*
  • Rats
  • Rats, Wistar
  • Running / physiology
  • Serotonin Antagonists / administration & dosage
  • Serotonin Antagonists / pharmacology*
  • Time Factors

Substances

  • Amidines
  • Ergolines
  • Placebos
  • Serotonin Antagonists
  • Quipazine
  • LY 53857
  • xylamidine